1. Quality control of a medicinal larval ( Lucilia sericata) debridement device based on released gelatinase activity.
- Author
-
PICKLES, S. F. and PRITCHARD, D. I.
- Subjects
- *
LUCILIA , *GELATINASES , *QUALITY control , *CHRONIC wounds & injuries , *MEDICAL equipment , *THERAPEUTICS - Abstract
Lucilia sericata Meigen ( Diptera: Calliphoridae) larvae are manufactured worldwide for the treatment of chronic wounds. Published research has confirmed that the primary clinical effect of the product, debridement (the degradation of non-viable wound tissue), is accomplished by a range of enzymes released by larvae during feeding. The quality assessment of larval activity is currently achieved during production using meat-based assays, which monitor insect growth and/or the reduction in substrate mass. To support this, the present authors developed a complementary radial diffusion enzymatic assay to produce a visual and measureable indication of the activity of larval alimentary products ( LAP) collected under standardized conditions, against a gelatin substrate. Using basic laboratory equipment and reagents, the assay is rapid and suited to high throughput. Assay reproducibility is high (standard deviation: 0.06-0.27; coefficient of variation: 0.75-4.31%) and the LAP collection procedure does not adversely affect larval survival (mortality: < 2%). Because it is both cost- and time-effective, this method is suited to both academic and industrial use and supports good manufacturing and laboratory practice as a quality control assay. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF